Novartis AG Common Stock (NVS)

Total Costs & Expenses

$38.64B

TTM · Period ending: · USD

NVS logo

NVS Total Costs & Expenses

Latest reported$38.64B
NVS TTM Total Costs & Expenses ($19.82B → $38.64B)
High-resolution chart · PNG

NVS total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novartis AG Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
18,623,000,000
18,560,000,000
19,817,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.